BAKER BROS. ADVISORS LP Diversified Active

CIK: 0001263508 · Show all filings

Period: Q4 2025 (← Previous)

Filing Date: Feb 17, 2026

Total Value ($000): $17,078,624 (99.6% shares, 0.4% debt)

Holdings (86)

New Positions (9)

Increased Positions (21)

KYMR Kymera Therapeutics, Inc. 3.9%
Value ($000) $673,620 (+78.9%) Shares 8,657,242 (+30.2%) Est. Cost $37.74 Unrealized +78.9%
PRAX Praxis Precision Medicines, Inc. 1.9%
Value ($000) $332,021 (+808.6%) Shares 1,126,488 (+63.4%) Est. Cost $99.31 Unrealized +87.5%
KOD Kodiak Sciences Inc. 3.3%
Value ($000) $556,940 (+96.5%) Shares 19,919,186 (+15.1%) Est. Cost $29.02 Unrealized -29.4%
IONS Ionis Pharmaceuticals, Inc. 0.8%
Value ($000) $141,753 (+282.3%) Shares 1,791,841 (+216.1%) Est. Cost $66.92 Unrealized +12.5%
ARWR Arrowhead Pharmaceuticals, Inc. 0.8%
Value ($000) $144,441 (+150.7%) Shares 2,175,645 (+30.2%) Est. Cost $24.96 Unrealized +96.4%
GRAL GRAIL, Inc. 1.0%
Value ($000) $178,484 (+85.2%) Shares 2,085,333 (+27.9%) Est. Cost $31.57 Unrealized +173.7%
CRNX Crinetics Pharmaceuticals, Inc. 0.4%
Value ($000) $76,755 (+558.2%) Shares 1,648,869 (+488.9%) Est. Cost $42.20 Unrealized +5.5%
ROIV Roivant Sciences Ltd. 0.7%
Value ($000) $120,544 (+111.5%) Shares 5,555,017 (+47.4%) Est. Cost $12.94 Unrealized +52.5%
SMMT Summit Therapeutics Inc. 3.7%
Value ($000) $636,480 (-8.6%) Shares 36,391,063 (+7.9%) Est. Cost $11.11 Unrealized +69.3%
NRIX Nurix Therapeutics, Inc. 0.5%
Value ($000) $88,373 (+146.4%) Shares 4,658,556 (+20.0%) Est. Cost $20.95 Unrealized -31.4%
ALKS Alkermes plc 1.6%
Value ($000) $280,143 (+15.4%) Shares 10,012,267 (+23.7%) Est. Cost $27.44 Unrealized +9.2%
IDYA IDEAYA Biosciences, Inc. 0.7%
Value ($000) $125,103 (+40.4%) Shares 3,618,826 (+10.5%) Est. Cost $20.65 Unrealized +54.4%
TRDA Entrada Therapeutics, Inc. 0.3%
Value ($000) $52,148 (+84.8%) Shares 5,072,730 (+4.3%) Est. Cost $16.68 Unrealized
VRDN Viridian Therapeutics, Inc. 0.4%
Value ($000) $61,359 (+63.0%) Shares 1,971,678 (+13.0%) Est. Cost $15.17 Unrealized +80.8%
VTYX Ventyx Biosciences, Inc. 0.1%
Value ($000) $21,214 (+566.7%) Shares 2,349,280 (+129.6%) Est. Cost $5.37 Unrealized +39.1%
TECX Tectonic Therapeutic, Inc. 0.1%
Value ($000) $18,845 (+1101.1%) Shares 903,400 (+803.4%) Est. Cost $20.13 Unrealized -7.7%
CTNM Contineum Therapeutics, Inc. 0.1%
Value ($000) $16,240 (+1679.5%) Shares 1,420,838 (+1729.3%) Est. Cost $11.67 Unrealized -2.2%
DSGN Design Therapeutics, Inc. 0.1%
Value ($000) $20,946 (+62.4%) Shares 2,233,099 (+30.4%) Est. Cost $11.07 Unrealized -29.3%
TARA Protara Therapeutics, Inc. 0.0%
Value ($000) $5,179 (+121.8%) Shares 971,614 (+81.0%) Est. Cost $9.86 Unrealized -43.6%
ELVN Enliven Therapeutics, Inc. 0.0%
Value ($000) $4,180 (+77.8%) Shares 271,406 (+136.3%) Est. Cost $17.98 Unrealized +10.8%
KALA KALA BIO, Inc. 0.0%
Value ($000) $1,003 (-33.5%) Shares 1,804,055 (+83.1%) Est. Cost $4.62 Unrealized -80.6%

Exited Positions (14)

Decreased Positions (7)

Unchanged Positions (49)

INCY Incyte Corporation 17.8%
Value ($000) $3,036,584 Shares 30,743,991 Est. Cost $72.80 Unrealized +32.9%
CELC Celcuity Inc. 4.6%
Value ($000) $789,521 Shares 7,915,792 Est. Cost $21.19 Unrealized +287.9%
ONC BeOne Medicines Ltd. 15.7%
Value ($000) $2,673,240 Shares 8,799,053 Est. Cost $136.93 Unrealized
RVMD Revolution Medicines, Inc. 4.4%
Value ($000) $753,119 Shares 9,455,357 Est. Cost $29.36 Unrealized +123.4%
MDGL Madrigal Pharmaceuticals, Inc. 7.3%
Value ($000) $1,247,198 Shares 2,141,701 Est. Cost $139.37 Unrealized +266.5%
ACAD ACADIA Pharmaceuticals Inc. 6.7%
Value ($000) $1,145,771 Shares 42,896,690 Est. Cost $18.93 Unrealized +26.2%
REPL Replimune Group, Inc. 0.6%
Value ($000) $107,361 Shares 11,045,336 Est. Cost $14.45 Unrealized -41.2%
IMVT Immunovant, Inc. 0.8%
Value ($000) $138,739 Shares 5,457,881 Est. Cost $22.96 Unrealized -2.9%
ABCL AbCellera Biologics Inc. 0.6%
Value ($000) $94,138 Shares 27,525,640 Est. Cost $21.02 Unrealized -78.8%
ABVX Abivax S.A. 0.7%
Value ($000) $118,105 Shares 875,796 Est. Cost $84.90 Unrealized
RYTM Rhythm Pharmaceuticals, Inc. 3.5%
Value ($000) $599,904 Shares 5,604,483 Est. Cost $23.49 Unrealized +351.7%
Celcuity Inc. 0.4%
Value ($000) $66,580 Shares 30,750,000 Est. Cost $1.33 Unrealized
IMTX Immatics N.V. 0.7%
Value ($000) $126,988 Shares 12,094,094 Est. Cost $8.55 Unrealized +18.0%
RARE Ultragenyx Pharmaceutical Inc. 0.4%
Value ($000) $63,772 Shares 2,772,692 Est. Cost $52.13 Unrealized -36.9%
SYRE Spyre Therapeutics, Inc. 0.2%
Value ($000) $32,760 Shares 1,000,000 Est. Cost $15.36 Unrealized +70.1%
PRLD Prelude Therapeutics Inc. 0.2%
Value ($000) $29,359 Shares 10,123,824 Est. Cost $28.24 Unrealized -94.0%
DBVT DBV Technologies S.A. 0.2%
Value ($000) $28,016 Shares 1,461,425 Est. Cost $3.09 Unrealized
ALMS Alumis Inc. 0.1%
Value ($000) $15,250 Shares 1,562,500 Est. Cost $13.30 Unrealized -47.5%
TSHA Taysha Gene Therapies, Inc. 0.1%
Value ($000) $22,026 Shares 4,004,756 Est. Cost $1.91 Unrealized +153.6%
DNLI Denali Therapeutics Inc. 0.4%
Value ($000) $61,610 Shares 3,731,695 Est. Cost $23.78 Unrealized -29.0%
BCYC Bicycle Therapeutics plc 0.5%
Value ($000) $77,068 Shares 10,885,357 Est. Cost $20.78 Unrealized
KNSA Kiniksa Pharmaceuticals International, plc 0.7%
Value ($000) $116,583 Shares 2,826,246 Est. Cost $18.73 Unrealized +114.1%
CERS Cerus Corporation 0.1%
Value ($000) $20,617 Shares 10,008,345 Est. Cost $4.19 Unrealized -58.6%
SION Sionna Therapeutics, Inc. 0.1%
Value ($000) $16,456 Shares 400,000 Est. Cost $16.34 Unrealized +132.1%
SKYE Skye Bioscience, Inc. 0.0%
Value ($000) $1,088 Shares 1,450,638 Est. Cost $7.74 Unrealized -81.1%
CTMX CytomX Therapeutics, Inc. 0.1%
Value ($000) $18,109 Shares 4,250,826 Est. Cost $1.73 Unrealized +119.9%
IRON Disc Medicine, Inc. 0.2%
Value ($000) $26,765 Shares 337,050 Est. Cost $49.46 Unrealized +70.9%
XNCR Xencor, Inc. 0.1%
Value ($000) $16,873 Shares 1,102,106 Est. Cost $16.65 Unrealized -10.2%
IMCR Immunocore Holdings plc 0.5%
Value ($000) $80,619 Shares 2,322,656 Est. Cost $38.09 Unrealized
RLAY Relay Therapeutics, Inc. 0.1%
Value ($000) $9,815 Shares 1,160,117 Est. Cost $13.78 Unrealized -48.2%
WVE Wave Life Sciences Ltd. 0.0%
Value ($000) $5,849 Shares 344,063 Est. Cost $5.98 Unrealized +70.0%
NGNE Neurogene Inc. 0.1%
Value ($000) $20,429 Shares 991,691 Est. Cost $19.35 Unrealized +28.6%
VTVT vTv Therapeutics, Inc. 0.0%
Value ($000) $5,931 Shares 148,314 Est. Cost $14.29 Unrealized +94.0%
TCRX TScan Therapeutics, Inc. 0.0%
Value ($000) $2,785 Shares 2,784,792 Est. Cost $6.08 Unrealized -76.2%
NUVL Nuvalent, Inc. 0.1%
Value ($000) $14,479 Shares 143,937 Est. Cost $73.17 Unrealized +34.8%
XENE Xenon Pharmaceuticals Inc. 0.1%
Value ($000) $16,593 Shares 370,208 Est. Cost $19.37 Unrealized +116.8%
DNTH Dianthus Therapeutics, Inc. 0.2%
Value ($000) $32,546 Shares 789,759 Est. Cost $18.76 Unrealized +106.7%
LBRX LB Pharmaceuticals Inc. 0.0%
Value ($000) $4,452 Shares 200,000 Est. Cost $15.87 Unrealized +10.1%
BNTX BioNTech SE 0.2%
Value ($000) $35,121 Shares 368,923 Est. Cost $107.38 Unrealized
PHVS Pharvaris N.V. 0.1%
Value ($000) $10,406 Shares 375,000 Est. Cost $22.18 Unrealized +8.6%
RAPP Rapport Therapeutics, Inc. 0.3%
Value ($000) $46,939 Shares 1,547,090 Est. Cost $15.27 Unrealized +81.3%
SGMT Sagimet Biosciences Inc. 0.0%
Value ($000) $5,642 Shares 952,996 Est. Cost $9.53 Unrealized -24.6%
CLDX Celldex Therapeutics, Inc. 0.1%
Value ($000) $18,071 Shares 665,370 Est. Cost $23.17 Unrealized +13.7%
SERA Sera Prognostics, Inc. 0.1%
Value ($000) $16,220 Shares 5,498,170 Est. Cost $3.09 Unrealized +4.2%
VIR Vir Biotechnology, Inc. 0.0%
Value ($000) $3,272 Shares 542,539 Est. Cost $7.89 Unrealized -24.5%
TYRA Tyra Biosciences, Inc. 0.0%
Value ($000) $279 Shares 10,607 Est. Cost $12.95 Unrealized +41.9%
ALGS Aligos Therapeutics, Inc. 0.0%
Value ($000) $774 Shares 83,055 Est. Cost $12.44 Unrealized -24.2%
ACRV Acrivon Therapeutics, Inc. 0.0%
Value ($000) $55 Shares 22,809 Est. Cost $4.64 Unrealized -53.2%
SRZNW Surrozen, Inc. 0.0%
Value ($000) $17 Shares 833,333 Est. Cost $1.14 Unrealized